×
DaVita Common Stock Net 2010-2025 | DVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
DaVita common stock net for the quarter ending June 30, 2025 was
$0.000B
, a
1.11% increase
year-over-year.
DaVita common stock net for 2024 was
$0B
, a
1.12% increase
from 2023.
DaVita common stock net for 2023 was
$0B
, a
1.11% decline
from 2022.
DaVita common stock net for 2022 was
$0B
, a
7.22% decline
from 2021.
View More
DaVita Common Stock Net 2010-2025 | DVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
DaVita common stock net for 2024 was
$0B
, a
1.12% increase
from 2023.
DaVita common stock net for 2023 was
$0B
, a
1.11% decline
from 2022.
DaVita common stock net for 2022 was
$0B
, a
7.22% decline
from 2021.
Related Stocks
Company Name
Market
Cap
Quest Diagnostics (DGX)
$20.4B
Encompass Health (EHC)
$12.3B
Elanco Animal Health (ELAN)
$8.7B
Chemed (CHE)
$6.6B
RadNet (RDNT)
$5.2B
Option Care Health (OPCH)
$4.6B
Amedisys (AMED)
$3.3B
Addus HomeCare (ADUS)
$2.1B
LifeStance Health (LFST)
$2.1B
Astrana Health (ASTH)
$1.7B
Aveanna Healthcare Holdings (AVAH)
$1.5B
U.S Physical Therapy (USPH)
$1.3B
Pennant (PNTG)
$864M
Atai Life Sciences (ATAI)
$851M
MEDIROM Healthcare Technologies (MRM)
$51M
Daxor (DXR)
$50M
Psychemedics (PMD)
$0M